1972
DOI: 10.1016/0041-3879(72)90013-x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1973
1973
1995
1995

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Patient noncompliance, acute infection with already resistant strains, and 40 years of ineffective administration of effective medicines have conspired to create a growing number of persons with resistant tuberculosis. Therapy of resistant tuberculosis is slower, more toxic, and more expensive than therapy of susceptible disease, with lower cure rates and an increased likelihood that the patient will remain infectious for an extended period (90,165,173,199,311). Research to identify genes coding for different antibiotic resistances appears promising and may lead to diagnostic and therapeutic innovations (325,350).…”
Section: Resistant Tuberculosis: Overviewmentioning
confidence: 99%
“…Patient noncompliance, acute infection with already resistant strains, and 40 years of ineffective administration of effective medicines have conspired to create a growing number of persons with resistant tuberculosis. Therapy of resistant tuberculosis is slower, more toxic, and more expensive than therapy of susceptible disease, with lower cure rates and an increased likelihood that the patient will remain infectious for an extended period (90,165,173,199,311). Research to identify genes coding for different antibiotic resistances appears promising and may lead to diagnostic and therapeutic innovations (325,350).…”
Section: Resistant Tuberculosis: Overviewmentioning
confidence: 99%